title: bioCSL Limited's 2009 clinical trial to assess the immunogenicity and safety of trivalent influenza vaccine in US children raises concern.
authors.affiliation: School of Pathology and Laboratory Medicine, University of Western Australia, Perth, Western Australia, Australia. Electronic address: pauleffler@gmail.com.
authors.forename: Paul V
authors.initials: PV
authors.lastname: Effler
authors.affiliation: National Centre for Epidemiology and Population Health, Australian National University, Canberra, ACT, Australia.
authors.forename: Heath A
authors.initials: HA
authors.lastname: Kelly
mesh_terms: D005260:Female; D006801:Humans; D007252:Influenza Vaccines / Q000009:adverse effects* / Q000276:immunology*; D007251:Influenza, Human / Q000517:prevention & control*; D008297:Male; D014611:Vaccination / Q000009:adverse effects* / Q000379:methods*
chemical_list: D007252:Influenza Vaccines